Cvi Holdings, LLC Seres Therapeutics, Inc. Transaction History

Cvi Holdings, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $7.35 Million - $20.7 Million	2,722,826 New	2,722,826 $9.34 Million
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $517,070 - $939,307	-225,795 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $514,812 - $1.66 Million	225,795 New	225,795 $727,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.